Formulation Scientist at Recipharm Pharmaceutical Development, Sweden
Dr. Daniel Tristan Osanloo is a dedicated researcher and formulation scientist based in Uppsala, Sweden. He recently completed his PhD at RISE AB/LTH, focusing on “Alternative drying technologies for biologics,” where he utilized advanced instruments such as freeze-dryers and spray dryers. His industry experience includes roles at prominent companies like Recipharm, Orexo AB, and AstraZeneca, where he contributed to the development of innovative pharmaceutical formulations. Dr. Osanloo has demonstrated strong leadership skills through his involvement in various community initiatives and board memberships, fostering collaboration and engagement. His academic background includes a pharmacy degree from Uppsala University, complemented by a master’s thesis on the de-agglomeration of micronized active pharmaceutical ingredients. With a commitment to advancing pharmaceutical sciences, Dr. Osanloo is poised to make significant contributions to the field and is an excellent candidate for recognition as a leading researcher.
Professional Profile
Education
Dr. Daniel Tristan Osanloo holds a PhD in Pharmaceutical Sciences from RISE AB and Lund University (LTH), which he completed in 2024. His doctoral research focused on “Alternative drying technologies for biologics,” exploring innovative methods beyond freeze-drying to enhance product stability and efficacy. Prior to his PhD, he earned a comprehensive pharmacy degree (300 hp) from Uppsala University, where he studied from 2011 to 2016. During his academic tenure, he conducted a master’s thesis project at Orexo AB, investigating the de-agglomeration of micronized active pharmaceutical ingredients, which laid the groundwork for his research expertise. Dr. Osanloo also completed an internship at Kronans Apotek, where he honed his communication skills and gained practical pharmacy experience. His educational background reflects a strong foundation in pharmaceutical sciences, complemented by hands-on training and a focus on innovative research methodologies.
Professional Experience
Dr. Daniel Tristan Osanloo has a robust professional background in pharmaceutical development and research. Currently, he serves as a Formulation Scientist at Recipharm Pharmaceutical Development in Solna, where he is responsible for developing solid, semi-solid, and liquid formulations, managing manufacturing methods, and preparing technical documentation for product stability studies. Previously, he completed his PhD at RISE AB/LTH, focusing on alternative drying technologies for biologics. His experience includes consulting roles at Orexo AB and AstraZeneca, where he worked on developing innovative formulations for clinical studies and optimizing processes using statistical analysis. Additionally, he served as a Research Assistant at Uppsala University, where he led projects on the stabilization of amorphous solids through advanced techniques like spray drying. Dr. Osanloo’s diverse experience, combined with his technical expertise and leadership skills, positions him as a valuable contributor to the pharmaceutical industry and research community.
Research Interests
Dr. Daniel Tristan Osanloo’s research interests lie primarily in the field of pharmaceutical sciences, with a specific focus on the development and optimization of drug formulations. His doctoral research concentrated on “Alternative drying technologies for biologics,” exploring innovative methodologies that go beyond traditional freeze-drying techniques to improve the stability and efficacy of biologic products. Dr. Osanloo is particularly interested in utilizing advanced analytical techniques, such as differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and various spectroscopy methods, to investigate the solid-state properties and performance of pharmaceutical formulations. Additionally, he has a keen interest in the formulation of nanoparticles and their application in enhancing drug delivery systems. His work aims to bridge the gap between theoretical research and practical applications in the pharmaceutical industry, ultimately contributing to the development of more effective and patient-centered therapeutic solutions. Through his research, Dr. Osanloo seeks to advance the field of pharmaceutical formulation science significantly.
Awards and Honors
Dr. Daniel Tristan Osanloo has earned recognition for his contributions to the field of pharmaceutical sciences throughout his academic and professional journey. Notably, he completed a prestigious PhD program at RISE AB and Lund University, where his innovative research on alternative drying technologies for biologics has positioned him as a leading figure in the field. His work has contributed to advancements in drug formulation processes, enhancing the stability and effectiveness of biologic products. In addition to his academic achievements, Dr. Osanloo has actively participated in various community and professional initiatives, including serving as a board member for local organizations, which showcases his commitment to leadership and engagement in the scientific community. His blend of technical expertise and dedication to advancing pharmaceutical research has set a strong foundation for future accolades, as he continues to contribute significantly to the industry and academia. Dr. Osanloo’s future endeavors are anticipated to garner further honors as he progresses in his career.
Conclusion
Daniel Tristan Osanloo demonstrates strong potential as a candidate for the Best Researcher Award due to his solid academic background, extensive research experience, and leadership capabilities. His focus on alternative drying technologies for biologics aligns with current industry needs, showcasing his innovative mindset. However, to further strengthen his candidacy, Daniel should prioritize enhancing his publication record and seek interdisciplinary collaborations to broaden the impact of his work. Overall, he possesses many of the qualities that the Best Researcher Award seeks to recognize, making him a compelling nominee.
Publications Top Noted
- Publication Title: The Impact of Formulation and Freeze Drying on the Properties and Performance of Freeze-Dried Limosilactobacillus reuteri R2LC
Authors: Tyagi, N., Gidlöf, Z., Osanlóo, D.T., Fureby, A.M., Roos, S.
Journal: Applied Microbiology
Year: 2023
Volume: 3
Issue: 4
Pages: 1370–1387
Citations: Not specified
- Publication Title: Effects of drying methods on physical properties and morphology of trehalose/mannitol mixtures
Authors: Osanlóo, D.T., Fransson, J., Bergenståhl, B., Millqvist-Fureby, A.
Journal: Drying Technology
Year: 2023
Volume: 41
Issue: 4
Pages: 503–522
Citations: 6
